Eupraxia Pharmaceuticals Closes $80.5 Million Public Offering

MT Newswires Live

09/24

Eupraxia Pharmaceuticals (EPRX) said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.

The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.

Shares of Eupraxia Pharmaceuticals were up more than 12% in recent Wednesday premarket activity.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2569702683"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569702683\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569702683?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-24 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569702683","market":"nz","top_or_hot":-1,"title":"Eupraxia Pharmaceuticals Closes $80.5 Million Public Offering","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/EPRX\">Eupraxia Pharmaceuticals</a> (EPRX) said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.</p><p>The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.</p><p>Shares of Eupraxia Pharmaceuticals were up more than 12% in recent Wednesday premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eupraxia Pharmaceuticals Closes $80.5 Million Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEupraxia Pharmaceuticals Closes $80.5 Million Public Offering\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-24 21:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/EPRX\">Eupraxia Pharmaceuticals</a> (EPRX) said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.</p><p>The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.</p><p>Shares of Eupraxia Pharmaceuticals were up more than 12% in recent Wednesday premarket activity.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EPRX","symbol_name":"Eupraxia Pharmaceuticals","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569702683","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569702683","pubTimestamp":1758720297,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Eupraxia Pharmaceuticals  said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.Shares of Eupraxia Pharmaceuticals were up more than 12% in recent Wednesday premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EPRX":"Eupraxia Pharmaceuticals","BK4139":"生物科技"},"translate_title":"Eupraxia Pharmaceuticals完成8050万美元公开募股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EPRX":1.5},"content_text":"Eupraxia Pharmaceuticals (EPRX) said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.Shares of Eupraxia Pharmaceuticals were up more than 12% in recent Wednesday premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}